Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone

B. Antus, Y. Yao, S. Liu, E. Song, J. Lutz, U. Heemann

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background. Donor and recipient gender influence long-term allograft outcome after kidney transplantation. Sex hormones are likely to contribute to these gender-related differences. The present study investigated the role of androgens and their inhibition on the development of chronic allograft nephropathy. Methods. Male or female Fisher (F344) kidneys were orthotopically transplanted into intact male Lewis recipients. Animals were treated either with testosterone, the antiandrogen flutamide, the 5α-reductase inhibitor finasteride, or vehicle. Twenty weeks after transplantation animals were harvested for histology, immunohistology, and molecular analysis. Results. Testosterone treatment resulted in an increased proteinuria as well as profound glomerulosclerosis, tubulointerstitial fibrosis, and mononuclear cell infiltration that paralleled enhanced intragraft mRNA levels of transforming growth factor-β (TGF-β) and platelet-derived growth factor-A and -B chain (PDGF-A and -B). In contrast, flutamide and finasteride reduced glomerulosclerosis as well as the inflammatory cell infiltration associated with decreased TGF-β, PDGF-A, and -B chain mRNA expression. No gender-related donor differences were noted between the groups. Conclusions. Our data suggest that dihydrotestosterone mediates the adverse effects of androgens on chronic allograft nephropathy. The inhibition of androgens improves long-term allograft outcome after kidney transplantation.

Original languageEnglish
Pages (from-to)1955-1963
Number of pages9
JournalKidney International
Volume60
Issue number5
DOIs
Publication statusPublished - 2001

Fingerprint

Dihydrotestosterone
Androgens
Allografts
Finasteride
Flutamide
Transforming Growth Factors
Kidney Transplantation
Testosterone
Proto-Oncogene Proteins c-sis
Androgen Antagonists
Messenger RNA
Gonadal Steroid Hormones
Proteinuria
Histology
Oxidoreductases
Fibrosis
Transplantation
Kidney
platelet-derived growth factor A
Therapeutics

Keywords

  • Donor gender
  • Glomerulosclerosis
  • Late graft loss
  • Sex hormone
  • Testosterone
  • Transplantation
  • Tubular atrophy

ASJC Scopus subject areas

  • Nephrology

Cite this

Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. / Antus, B.; Yao, Y.; Liu, S.; Song, E.; Lutz, J.; Heemann, U.

In: Kidney International, Vol. 60, No. 5, 2001, p. 1955-1963.

Research output: Contribution to journalArticle

Antus, B. ; Yao, Y. ; Liu, S. ; Song, E. ; Lutz, J. ; Heemann, U. / Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. In: Kidney International. 2001 ; Vol. 60, No. 5. pp. 1955-1963.
@article{ddd79111181d4e3abaf71920b837cf3b,
title = "Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone",
abstract = "Background. Donor and recipient gender influence long-term allograft outcome after kidney transplantation. Sex hormones are likely to contribute to these gender-related differences. The present study investigated the role of androgens and their inhibition on the development of chronic allograft nephropathy. Methods. Male or female Fisher (F344) kidneys were orthotopically transplanted into intact male Lewis recipients. Animals were treated either with testosterone, the antiandrogen flutamide, the 5α-reductase inhibitor finasteride, or vehicle. Twenty weeks after transplantation animals were harvested for histology, immunohistology, and molecular analysis. Results. Testosterone treatment resulted in an increased proteinuria as well as profound glomerulosclerosis, tubulointerstitial fibrosis, and mononuclear cell infiltration that paralleled enhanced intragraft mRNA levels of transforming growth factor-β (TGF-β) and platelet-derived growth factor-A and -B chain (PDGF-A and -B). In contrast, flutamide and finasteride reduced glomerulosclerosis as well as the inflammatory cell infiltration associated with decreased TGF-β, PDGF-A, and -B chain mRNA expression. No gender-related donor differences were noted between the groups. Conclusions. Our data suggest that dihydrotestosterone mediates the adverse effects of androgens on chronic allograft nephropathy. The inhibition of androgens improves long-term allograft outcome after kidney transplantation.",
keywords = "Donor gender, Glomerulosclerosis, Late graft loss, Sex hormone, Testosterone, Transplantation, Tubular atrophy",
author = "B. Antus and Y. Yao and S. Liu and E. Song and J. Lutz and U. Heemann",
year = "2001",
doi = "10.1046/j.1523-1755.2001.00007.x",
language = "English",
volume = "60",
pages = "1955--1963",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone

AU - Antus, B.

AU - Yao, Y.

AU - Liu, S.

AU - Song, E.

AU - Lutz, J.

AU - Heemann, U.

PY - 2001

Y1 - 2001

N2 - Background. Donor and recipient gender influence long-term allograft outcome after kidney transplantation. Sex hormones are likely to contribute to these gender-related differences. The present study investigated the role of androgens and their inhibition on the development of chronic allograft nephropathy. Methods. Male or female Fisher (F344) kidneys were orthotopically transplanted into intact male Lewis recipients. Animals were treated either with testosterone, the antiandrogen flutamide, the 5α-reductase inhibitor finasteride, or vehicle. Twenty weeks after transplantation animals were harvested for histology, immunohistology, and molecular analysis. Results. Testosterone treatment resulted in an increased proteinuria as well as profound glomerulosclerosis, tubulointerstitial fibrosis, and mononuclear cell infiltration that paralleled enhanced intragraft mRNA levels of transforming growth factor-β (TGF-β) and platelet-derived growth factor-A and -B chain (PDGF-A and -B). In contrast, flutamide and finasteride reduced glomerulosclerosis as well as the inflammatory cell infiltration associated with decreased TGF-β, PDGF-A, and -B chain mRNA expression. No gender-related donor differences were noted between the groups. Conclusions. Our data suggest that dihydrotestosterone mediates the adverse effects of androgens on chronic allograft nephropathy. The inhibition of androgens improves long-term allograft outcome after kidney transplantation.

AB - Background. Donor and recipient gender influence long-term allograft outcome after kidney transplantation. Sex hormones are likely to contribute to these gender-related differences. The present study investigated the role of androgens and their inhibition on the development of chronic allograft nephropathy. Methods. Male or female Fisher (F344) kidneys were orthotopically transplanted into intact male Lewis recipients. Animals were treated either with testosterone, the antiandrogen flutamide, the 5α-reductase inhibitor finasteride, or vehicle. Twenty weeks after transplantation animals were harvested for histology, immunohistology, and molecular analysis. Results. Testosterone treatment resulted in an increased proteinuria as well as profound glomerulosclerosis, tubulointerstitial fibrosis, and mononuclear cell infiltration that paralleled enhanced intragraft mRNA levels of transforming growth factor-β (TGF-β) and platelet-derived growth factor-A and -B chain (PDGF-A and -B). In contrast, flutamide and finasteride reduced glomerulosclerosis as well as the inflammatory cell infiltration associated with decreased TGF-β, PDGF-A, and -B chain mRNA expression. No gender-related donor differences were noted between the groups. Conclusions. Our data suggest that dihydrotestosterone mediates the adverse effects of androgens on chronic allograft nephropathy. The inhibition of androgens improves long-term allograft outcome after kidney transplantation.

KW - Donor gender

KW - Glomerulosclerosis

KW - Late graft loss

KW - Sex hormone

KW - Testosterone

KW - Transplantation

KW - Tubular atrophy

UR - http://www.scopus.com/inward/record.url?scp=0034773379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034773379&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2001.00007.x

DO - 10.1046/j.1523-1755.2001.00007.x

M3 - Article

VL - 60

SP - 1955

EP - 1963

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -